Search results

  1. B

    PFACP is interesting ... short trap?

    PFACP is a cumulative preferred issue traded on NASDAQ which took a dive last year from $18-$20 to $5 after they discontinued the dividend and said that they don't expect to reinstate it. Stock price has risen from $5s last December to $14.96 this month with no apparent reason. Last year...
  2. B

    AVNR revisited

    I doubt that they will stay alive long enough for them to ever finish another clinical trial. They had already lost two partners this year and today Astra-Zeneca pulled the plug on a cardio drug they were working with AVNR on. Sales from Abreva and Fazaclo will not be enough to pay for even...
  3. B

    Keep An Eye On CBLI...

    umm. no. i think you're comparing the HYPE from CBLI to the DATA from HEPH. i'm not interested in the dreams they get from the dope they're smoking. i've been following HEPH and Neumune for at least 5 years. the drug is a steroid that stimulates the bone marrow. it doesn't have...
  4. B

    Keep An Eye On CBLI...

    http://finance.yahoo.com/q/bc?s=CBLI&t=5d&l=on&z=l&q=l&c= tells me that if $8.85 does not hold (and why should it?), $8.50 is next.
  5. B

    Keep An Eye On CBLI...

    CBLI falling like a rock on the sucker rally today: http://finance.yahoo.com/q/bc?s=cbli&t=1d i'll holding out for the $8.50 level it hit after they announced the secondary. the "other player" besides HHS and DoD is NASA. like i said earlier, NASA gave CBLI a GRANT to look at protecting...
  6. B

    Keep An Eye On CBLI...

    i don't see what you're talking about with side effect differences between Neumune and Protectan. localized irritation at injection site is what every body bulder who injects steroids has lived with for a long time. Neumune has been studied with AFRRI for 10 years. i have not seen a logical...
  7. B

    Keep An Eye On CBLI...

    ok. i'll pay up for a small number of CBLI shares at $8.85, today's bottom at 10:29 AM. the trading seems to be indicating Distribution but that's just by eye-ball. i think that some people who paid up more than $10 are tryin to get out because they have discovered this is a hyped stock...
  8. B

    Keep An Eye On CBLI...

    hmm. well, my latest volunteer work for a nuclear watchdog group went to a dead end so i can post again. yes. stoney. i will but CBLI again and almost bought some yesterday at the close for $8.90. i've been trying to get it for $8.50. it's a definite buy in the $8s. i stil think that...
  9. B

    Keep An Eye On CBLI...

    no other shoe. Akorn is playing a totally different type of exercise. it's like comparing yoga to football. it's apples and oranges comparing chelating (or other clearing/blocking) agents like KI/Prussian Blue/EDTA or DTPA/beer for tritium/ on the one hand ... to, on the other hand, the...
  10. B

    Keep An Eye On CBLI...

    something funny here. it won't let me quote your post, SI, but i can post a general reply to the thread. Potassium iodide (KI) pills are blocking agents, not the clearing agents from Akorn. Other clearing agents are EDTA (for Pu and other heavy metals) and Prussian Blue (for cesium and...
  11. B

    Keep An Eye On CBLI...

    RAE is the company that sells most of networked detectors. Stock price very cheap. If you found out they're getting the contract you could score big. "spooking you out"? if you only knew 1% of the horror stories i know ... i could tell you about the FedEx package of brachytherapy seeds...
  12. B

    Keep An Eye On CBLI...

    OK. Basically, ever since Chernobyl (April/May 1984), we know for sure that it's the bone-marrow syndrome (not GI) which kills people with ARS. Besides the testes (which are highly radiosensitive) in men, and a human zygote/embryo/fetus in a pregnant woman, the cells in the body which are...
  13. B

    Keep An Eye On CBLI...

    I haven't the foggiest idea why DoD is focusing on GI syndrome and ignoring neutropenia. They're going against all the standard guidance books for treating people exposed to radiation in emergencies. They're going against common knowledge among nuke safety experts, and all public data...
  14. B

    Keep An Eye On CBLI...

    from: http://money.excite.com/jsp/nw/nwdt_ge.jsp?news_id=cmt-354p2762&feed=cmt&date=20061220 Up to one hour after exposure? And that claim is based on mice, not monkeys. Sounds like a sure thing ... Not!
  15. B

    Keep An Eye On CBLI...

    Any generic drug maker could easily do that job to FDA standards. How much are they getting a dose? Over $40 per dose? A Mylan or a Teva could easily have underbid Akorn. They're "clearing agents" like Prussian Blue (for CS and Th) and EDTA (for Pu) intakes. When there was a tritium...
  16. B

    Keep An Eye On CBLI...

    Here it is: http://hsc-democrats.house.gov/press/index.asp?ID=186 The Future of BioShield in Question? FOR IMMEDIATE RELEASE: Wednesday, March 07, 2007 Wednesday, March 7, 2007 (WASHINGTON) – Today, the Department of Health and Human Services cancelled a BioShield RFP for a...
  17. B

    Keep An Eye On CBLI...

    Check this out. Congresisonal Reps. Thompson and Langevin issued a press release, which i'm having a hard time finding, but it was the basis for this news story. http://news.yahoo.com/s/usnw/20070308/pl_usnw/the_future_of_bioshield_in_question The Future of BioShield in Question? Wed...
  18. B

    Keep An Eye On CBLI...

    If HHS is now doing an illegal side deal with CBLI (involving leaked info and insider trading) to cheat HEPH out of the contract, you will be seeing a lot of fireworks coming from Congressional hearings. Remember that HEPH is from California and so are Reps. Waxman and Pelosi. HHS' authority...
  19. B

    Keep An Eye On CBLI...

    DoD is exempt from FDA/HHS regulation when it comes to protecting the troops. as Hollis just said, DoD was "hoping" to "piggyback" on a Project Bioshield procurement, but they are free (now) to go ahead with a military procurement (where Neumune could *only* be given to military personnel)...
  20. B

    Keep An Eye On CBLI...

    listen to the HEPH CC. Protectan is literally years behind Neumune, which has already met all the HHS requirements per their procurment. HHS is lying if they said that it did not satisfy the technical requirements. HEPH is requesting a "debriefing" from HHS at which they should learn what...
Back
Top